Skip to main content
Premium Trial:

Request an Annual Quote

Joe Bernardo

Joe Bernardo has been named chairman of the board of SeraCare Life Sciences. Bernardo is also an operating partner at Linden Capital Partners, the equity investors behind SeraCare. Prior to these roles, he served as president of the next-generation sequencing and oncology division at Thermo Fisher Scientific. He has also worked for Siemens Healthcare, where he was senior vice president of the central lab business unit, and Abbott Laboratories.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.